Cargando…
A systematic in vitro investigation on poly-arginine modified nanostructured lipid carrier: Pharmaceutical characteristics, cellular uptake, mechanisms and cytotoxicity
The aim of the present study was to develop a poly-arginine modified nanostructured lipid carrier (R-NLC) by fusion-emulsification method and to test its pharmaceutical characteristics. The influence of R-NLC on A549 cells like cellular uptake and cytotoxicity was also appraised using unmodified NLC...
Autores principales: | Sun, Mingshuang, Gao, Yunyun, Zhu, Zhihong, Wang, Huixin, Han, Cuiyan, Yang, Xinggang, Pan, Weisan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shenyang Pharmaceutical University
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032249/ https://www.ncbi.nlm.nih.gov/pubmed/32104313 http://dx.doi.org/10.1016/j.ajps.2016.07.007 |
Ejemplares similares
-
Surface density of polyarginine influence the size, zeta potential, cellular uptake and tissue distribution of the nanostructured lipid carrier
por: Sun, Mingshuang, et al.
Publicado: (2017) -
Sterically Stabilized RIPL Peptide-Conjugated Nanostructured Lipid Carriers: Characterization, Cellular Uptake, Cytotoxicity, and Biodistribution
por: Kim, Chang Hyun, et al.
Publicado: (2018) -
An Innovative Formulation Based on Nanostructured Lipid Carriers for Imatinib Delivery: Pre-Formulation, Cellular Uptake and Cytotoxicity Studies
por: Gundogdu, Evren, et al.
Publicado: (2022) -
Nanostructured lipid carrier surface modified with Eudragit RS 100 and its potential ophthalmic functions
por: Zhang, Wenji, et al.
Publicado: (2014) -
Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells
por: Zhou, Jianwen, et al.
Publicado: (2019)